Filtrona plc
12 January 2007
FILTRONA PLC
HOLDING (S) IN COMPANY
12 January 2007
Filtrona plc announces it was informed on 12 January 2007 that, following an
acquisition on 9 January 2007, Morgan Stanley Securities Limited ('MSSL') holds
an interest in 7,007,449 ordinary 25p shares, being 3.19% of the issued share
capital of the Company.
MSSL have transferred from time to time 4,067,340 ordinary shares to third
parties on terms which give them the right to require return of an equivalent
number of shares. MSSL's interest in 4,067,340 ordinary shares is pursuant to
Section 208(5) of the Companies Act 1985.
Filtrona plc was advised that MSSL is a member of the Morgan Stanley group of
companies. Those group companies which are direct or indirect holding companies
of MSSL are each interested by attribution in any shares in which MSSL is
interested.
Name of contact and telephone number for queries
Patricia Kingdon
Deputy Company Secretary
T: 01908 359100
Name of authorised company official responsible for making this notification
Jon Green
General Counsel and Company Secretary
T: 01908 359100
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.